Currency headwinds quell drug gains in Q4; says Merck KGaA Garima10 March 2019 8:59 AM ISTFRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health Ruby Khatun Khatun12 Sept 2017 9:47 AM ISTJERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...